| 10/07/2026 7:30 AM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/31/2026 3:52 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 3:10 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 07/17/2026 3:37 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/17/2026 3:49 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 07/13/2026 12:28 PM | CERo Therapeutics (1870404) Subject Nasdaq Stock Market LLC (1354457) Filed by | Form 25-NSE | |
| 06/26/2026 3:05 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/29/2026 3:15 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 05/29/2026 3:05 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 3:32 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 04/30/2026 3:34 PM | CERo Therapeutics (1870404) Filer | Form 10-K/A | |
Get the Latest News and Ratings for CERO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/21/2026 6:46 PM | CERo Therapeutics (1870404) Issuer Francois Eric (1656125) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/21/2026 6:46 PM | CERo Therapeutics (1870404) Issuer Francois Eric (1656125) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:59 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 04/15/2026 3:05 PM | CERo Therapeutics (1870404) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 04/14/2026 3:01 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/14/2026 3:03 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 04/01/2026 3:10 PM | CERo Therapeutics (1870404) Filer | Form NT 10-K | |
| 03/12/2026 2:38 PM | CERo Therapeutics (1870404) Subject Tibbs Isaiah (2116034) Filed by | Form SCHEDULE 13G | |
| 02/04/2026 8:18 AM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 02/04/2026 8:12 AM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 4:15 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:30 PM | CERo Therapeutics (1870404) Issuer KUCHARCHUK ANDREW ALBERT (1654127) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | Byrnes Michael (1619893) Reporting CERo Therapeutics (1870404) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | CERo Therapeutics (1870404) Issuer Ehrlich Christopher B (1293973) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | ATWOOD BRIAN G (1266567) Reporting CERo Therapeutics (1870404) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | CERo Therapeutics (1870404) Issuer Patel Shami (1378251) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | CERo Therapeutics (1870404) Issuer Pierce Kristen (2039649) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | CERo Therapeutics (1870404) Issuer LAPORTE KATHLEEN (1196201) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 3:30 PM | CERo Therapeutics (1870404) Issuer Rolfe Lindsey (1650504) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 3:05 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 01/07/2026 3:37 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 4:24 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 12/19/2025 3:49 PM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/11/2025 11:15 PM | CERo Therapeutics (1870404) Filer | Form EFFECT | |
| 12/05/2025 4:12 PM | CERo Therapeutics (1870404) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/02/2025 4:17 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 12/02/2025 4:18 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 12/02/2025 3:10 PM | CERo Therapeutics (1870404) Filer | Form DEFA14A | |
| 12/02/2025 7:30 AM | CERo Therapeutics (1870404) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 7:31 AM | CERo Therapeutics (1870404) Filer | Form DEF 14A | |
ELON + YOU + DECEMBER 8TH (Ad) Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th.
A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet. Watch the free Masterclass now to learn what happens on December 8th |
| 11/20/2025 3:05 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 11/20/2025 3:05 PM | CERo Therapeutics (1870404) Filer | Form 424B3 | |
| 11/19/2025 3:10 PM | CERo Therapeutics (1870404) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |